funding Archives - Sanford Burnham Prebys

Tag: funding

Institute News

Mark your calendars: Padres Pedal the Cause is back

AuthorMiles Martin
Date

January 20, 2022

Team Sanford Burnham Prebys photo

Ride with Sanford Burnham Prebys this April

Sanford Burnham Prebys is gearing up for next year’s Padres Pedal the Cause (PPTC), an annual fundraising race that invites participants to cycle, spin, run or walk to support cancer research in the San Diego area. The event, scheduled for April 9, 2022, at Petco Park, is currently planned to be held in person for the first time since the beginning of the pandemic.

Leveraging the power of San Diego
PPTC was founded in 2013 by two-time lymphoma survivor Bill Koman and his wife, Amy. Thankful for the lifesaving care that Bill received, the Koman family was determined to pay it forward to ensure that others had the same outcome. With this goal in mind, the couple created PPTC, a cancer fundraising cycling challenge operating in partnership with the San Diego Padres.

Since the inaugural ride of PPTC, the organization has raised more than $15 million and funded 73 collaborative research projects in San Diego, including six clinical trials. They’ve also expanded and grown, merging with the Immunotherapy Foundation under a new name: Curebound.

Together, these two organizations share the belief that discovering a cure for cancer can be made possible by harnessing the unique power of San Diego—home to three nationally recognized National Institutes of Health cancer institutions and a renowned pediatric hospital. Last year, Curebound welcomed two new research partners: La Jolla Institute for Immunology and Scripps Research. They join Sanford Burnham Prebys, Moores Cancer Center at UC San Diego, the Salk Institute, and Rady Children’s Hospital in collaborating to accelerate cancer research into cures.

A pivotal year for Padres Pedal the Cause
This is an important year for PPTC. After a record-breaking event in 2019—which had almost 3,000 participants and raised more than $3 million—COVID-19 presented challenges. The next PPTC event wasn’t held until spring 2021, moving to a virtual format due to the pandemic.

That event had 1,578 participants and raised $1.5 million. And while these numbers demonstrate the commitment of the Pedal the Cause community to continue their good work despite the pandemic, the amount is less than that received for the 2019 event, demonstrating the obstacles the community faced to raise those funds.

Now, PPTC is ready to ride at full speed for the first time in more than two years.

Join Team Sanford Burnham Prebys
Padres Pedal the Cause ’22 will take place on April 9, 2022, at Petco Park, and registration is now open for the Sanford Burnham Prebys team. Whether you’re ready to ride, run, walk, spin, participate virtually or even just cheer from the sidelines, 100% of every dollar raised funds lifesaving cancer research.

Ride with Sanford Burnham Prebys this April, and help us create a world without cancer.

Join Team Sanford Burnham Prebys

Institute News

Ze’ev Ronai receives Outstanding Investigator grant

Authorjmoore
Date

February 3, 2016

Header image

A renowned cancer researcher at Sanford Burnham Prebys Medical Discovery Institute (SBP) has received a National Cancer Institute (NCI) Outstanding Investigator Award (OIA) for cancer research with breakthrough potential. Ze’ev Ronai, PhD, is scientific director of SBP’s La Jolla campus and professor of its NCI-designated Cancer Center. He will receive $7.9 million over a seven-year period to advance his cancer research. Continue reading “Ze’ev Ronai receives Outstanding Investigator grant”

Institute News

21st Century Cures Act will benefit SBP in Lake Nona, according to Orlando Medical News

Authorjmoore
Date

January 27, 2016

Header image

A recent article highlighted how the federal 21st Century Cures Act will benefit Orlando-area research institutes, including SBP. The legislation, which was passed by the House of Representatives in July, would promote medical research and accelerate the translation of discoveries into new drugs and medical devices by increasing funding for the National Institute of Health (NIH) and making research and healthcare policy changes.

The 21st Century Cures Act, which remains to be passed by the Senate, calls for annual increases in the stagnating budget for the NIH amounting to about 3% per year for 3 years when adjusted for inflation, as well as an additional $2 billion per year for 5 years to create an “NIH Innovation Fund.” NIH funding was recently increased by $2 billion (6.7%) in December as part of the 2016 budget.

The article quotes Stephen Gardell, PhD, senior director of Scientific Resources at SBP, on the importance of NIH funding: “The NIH is making an investment in the work of researchers and looking for a return on that investment—discoveries that will provide the foundation for new therapies and new devices that will improve human health and combat disease.”

Gardell’s research focus involves the profiling of metabolites in blood, urine and tissues to discover novel biomarkers. Large-scale profiling of metabolites enabled by remarkable advances in mass spectrometry has created a new area of research called metabolomics. Hundreds of different metabolites (“biomarker candidates”) can now be measured in a single drop of blood. The metabolite profile provides a signature of health, disease and drug action that can help to recognize a disease early and guide the care provider to select the right drug.

Gardell also emphasized that SBP is well equipped to carry out the translation of discoveries from bench to bedside that the act is intended to promote. He described the SBP drug discovery program as “a very capable and powerful resource that is modeled after the infrastructure in the world-leading pharmaceutical companies.”